China Rich List 2015: Top 400 Chinese Billionaires And Billionaire Families

101. Jiang Zhaobai, Shanghai Pengxin Group, 52, real estate, $2.3 billion

101. Ruan Shuilong, Zhejiang Longsheng Group, 79, chemicals, $2.3 billion

103. Jiang Wei, Guizhou Bailing Group Pharmaceutical, 53, pharmaceuticals, $2.25 billion

103. Feng Hailiang, China Hailiang Group, 55, diversified, $2.25 billion

103. Cao Longxiang, Jumpcan Pharmaceutical Group, 58, pharmaceuticals, $2.25 billion

103. Du Jiangtao, Inner Mongolia Junzheng Energy, 45, chemicals, $2.25 billion

103. Geng Jianming, RiseSun Real Estate, 53, real estate, $2.25 billion

103. Huang Qisen, Thaihot Group, 50, real estate, $2.25 billion

109. Wu Yiling, Shijiazhuang Yiling Pharmaceutical, 66, pharmaceuticals, $2.2 billion

110. Zhang Guiping, Suning Universal, 64, real estate, $2.15 billion

110. Liu Zhiqiang, Heung Kong Group, 51, conglomerate, $2.15 billion

110. Tian Ming, Hefei Meiya Optoelectronic Technology, 61, measuring instruments, $2.15 billion

110. Cai Dongqing, Guangdong Alpha Animation and Culture, 46, animation, $2.15 billion

110. Liu Baolin, Jointown Pharmaceutical Group, 62, pharmacies, drug distribution, $2.15 billion

110. Chen Jinsong, Shenzhen Worldunion Properties Consultancy, 51, real estate, $2.15 billion

116. Chen Bang, Aier Eye Hospital, 50, hospitals, $2.1 billion

116. Zhu Gongshan, GCL-Poly Energy, 57, solar energy materials, $2.1 billion

116. Chen Jianhua, Hengli Group, 44, chemicals, $2.1 billion

116. Liu Changqing, Liaoning Julong Financial Equipment, 62, manufacturing, $2.1 billion

116. Ao Xiaoqiang, Beijing SDL Technology, 51, electrical equipment manufacturing, $2.1 billion

121. Shuai Fangwen, Hunan Er-kang Pharmaceutical, 49, pharmaceuticals, $2.05 billion

122. Qi Shi, East Money Information, 45, Internet, $2 billion

122. Chanchai Ruayrungruang, Reignwood Group, 61, real estate, $2 billion

122. Gu Wei, Shenzhen MTC, 50, consumer electronics, $2 billion

122. Wei Shaojun, Longjitaihe, 52, real estate, $2 billion

122. Wu Jianshu, Ningbo Tuopu Group, 51, auto parts, $2 billion

122. Lei Jufang, Tibet Cheezheng Tibetan Medicine, 62, pharmaceuticals, $2 billion

122. Yang Zhimao, Guangdong Golden Dragon Development, 52, utilities, real estate, $2 billion

122. Zhou Guohui, Eternal Asia Supply Chain Management, 50, logistics, $2 billion

122. Zhou Fuhai, Jiangsu Asia-Pacific Light Alloy Technology, 55, aluminum products, $2 billion

131. Ye Cheng, Shandong Landbridge Group, 53, diversified, $1.95 billion

131. Liu Xuejing, GMK Holdings, 64, copper, poultry, $1.95 billion

131. Lin Jianhua, Hangzhou First PV Material, 53, solar, $1.95 billion

131. Nan Cunhui, Zhejiang Chint Electrics, 52, electrical power equipment, $1.95 billion

131. Fu Meicheng, Huace Film & TV, 58, film production, $1.95 billion

131. Wang Junmin, Haisco Pharmaceutical Group, 46, pharmaceuticals, $1.95 billion

137. Zheng Xiaodong, Shanghai Tofflon Science and Technology, 51, manufacturing, $1.9 billion

137. Hu Kaijun, Huadong Medicine, 53, pharmaceuticals, $1.9 billion

137. Cao Kejian, Zhejiang Kaishan Compressor, 53, air compressors, $1.9 billion

137. Lin Li, Shenzhen Liye Group, 52, investments, $1.9 billion

137. Zhang Li, Guangzhou R&F Properties, 62, real estate, $1.9 billion

137. Huang Qiaoling, Hangzhou Songcheng Tourism Development, 56, tourism, $1.9 billion

137. Wen Jianping, Beijing Originwater Technology, 53, sewage treatment, $1.9 billion

137. Li Yihai, Jiangxi Jiminkexin Group, 52, pharmaceuticals, $1.9 billion

137. Zan Shengda, Zongyi Group, 52, diversified, $1.9 billion

137. Xu Jingren, Yangtze River Pharmaceutical Group, 71, pharmaceuticals, $1.9 billion

137. He Junming, Kechuang Holding Group, 57, pharmaceuticals, $1.9 billion

148. Che Fengsheng, Sihuan Pharmaceutical, 52, pharmaceuticals, $1.85 billion

148. Shao Zhongyi, Shandong Sunrise Group, 47, soybean trading, $1.85 billion

148. Xiong Xuqiang, Yinyi Real Estate, 59, real estate, $1.85 billion

148. Zhou Wei, Shanghai Kingstar Winning Software, 48, software, $1.85 billion

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name